1. Adriamycin induced resistance of sensitive K562 cells to natural killer lymphocyte attack;Benoist;Cancer Immun. Immunotherap.,1985
2. Genetic regulation and specificity of murine natural antitumor antibodies and natural killer cells;Chow;J. natn. Cancer Inst.,1981
3. Increase in sensitivity of the microcytotoxicity assay by T cell growth factor (IL-2)-containing preparations;Indrova;Folia biologica Prague,1984
4. Enhancement of murine lymphoma cell lysability by CTL and by LAK cells, after treatments with mitomycin C and with adriamycin;Leroux;Int. J. Immunopharmac.,1986
5. The synergistic tumoricidal activity of anticancer drugs and oxidative burst-triggered macrophages;Marcovitch;Cancer Immun. Immunotherap.,1985